Tower Research Capital LLC (Trc) Acasti Pharma Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.85 - $1.29 $520 - $789
-612 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$0.94 - $1.43 $256 - $390
273 Added 80.53%
612 $1,000
Q4 2021

Feb 14, 2022
BUY
$1.07 - $2.01 $157 - $295
147 Added 76.56%
339 $0
Q3 2021

Nov 15, 2021
BUY
$1.96 - $4.72 $376 - $906
192 New
192 $0

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $146M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email